Aurinia Pharmaceuticals Stock (NASDAQ:AUPH), Quotes and News Summary

Q: What sector and industry does Aurinia Pharmaceuticals (AUPH) operate in?

Aurinia Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

Aurinia Pharmaceuticals Stock (NASDAQ: AUPH) stock price, news, charts, stock research, profile.

Open	$5.170
Close	$5.170
Volume / Avg.	792.055K / 2.105M
Day Range	5.100 - 5.210
52 Wk Range	4.710 - 12.430
Market Cap	$739.410M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	53
Short Interest	8.01%
Days to Cover	8.48

Recent News

Analog Devices To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Avi Kapoor

Why Herbalife Shares Are Trading Lower By Around 36%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Herbalife Ltd. (NYSE: HLF) fell sharply in today’s session following weak quarterly earnings.

Avi Kapoor

Aurinia Pharmaceuticals Finds No Buyer After Strategic Business Review, Launches Stock Buyback

Aurinia Pharmaceuticals Q4 2023 results: EPS loss $(0.19), sales $45.1 million. AUR200 development halted. Strategic review concludes. $150 million share buyback initiated.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Aurinia Pharmaceuticals (AUPH) stock?

You can purchase shares of Aurinia Pharmaceuticals (NASDAQ: AUPH) through any online brokerage.

View our list of the best stock brokerages.

Who are Aurinia Pharmaceuticals's (AUPH) competitors?

There are no as such competitors for Aurinia Pharmaceuticals.

What is the target price for Aurinia Pharmaceuticals (AUPH) stock?

The latest price target for Aurinia Pharmaceuticals (NASDAQ: AUPH) was reported by HC Wainwright & Co. on Friday, March 1, 2024. The analyst firm set a price target for 13.00 expecting AUPH to rise to within 12 months (a possible 151.45% upside). 7 analyst firms have reported ratings in the last year.

Current Stock Price for Aurinia Pharmaceuticals (AUPH)?

The stock price for Aurinia Pharmaceuticals (NASDAQ: AUPH) is $5.17 last updated May 9, 2024 at 6:17 PM EDT.

Does Aurinia Pharmaceuticals (AUPH) pay a dividend?

There are no upcoming dividends for Aurinia Pharmaceuticals.

When is Aurinia Pharmaceuticals (NASDAQ:AUPH) reporting earnings?

Aurinia Pharmaceuticals’s Q2 earnings are confirmed for Thursday, August 1, 2024.

Is Aurinia Pharmaceuticals (AUPH) going to split?

There is no upcoming split for Aurinia Pharmaceuticals.

What sector and industry does Aurinia Pharmaceuticals (AUPH) operate in?

Aurinia Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.